Using groundbreaking studies to drive effective, new cancer treatments is the core principle of research at Atlantic Health System Cancer Care. In addition to featuring many of the nation’s top doctors and researchers, we have partnerships with industry and cooperative groups that allow us to provide our communities with the latest cancer clinical trials.
Pioneers in Cancer Research
With many of our clinical trials, such as our treatments for gioblastoma and HPV-associated cancers, we are one of only a handful of sites in the country offering them. Other accomplishments include:
- The Atlantic Melanoma Center was the first in the world to enroll a patient in a Phase IIa trial of a virus-based immunotherapy.
- Overlook Medical Center enrolled the most patients in the region (NJ, NY, CT, PA and DE) into the international TAILORx breast cancer study.
- The Women’s Cancer Center was one of six centers in the nation to participate in an MD Andersen Cancer Center clinical trial for the early detection of ovarian cancer.
- Atlantic Health System was the first health system selected by Translational Genomics Research Institute and Origin to create the Breakthrough Oncology Accelerator.
Breakthrough Oncology Accelerator
Atlantic Health System and Translational Genomics Research Institute (TGen) have entered into a partnership knowing as the Breakthrough Oncology Accelerator, which will promote faster access to innovative cancer treatments and reduce financial barriers by developing new payment models.